Pressure Ulcers – Pipeline Review including key players EyeGene Inc,Izun Pharmaceuticals Corp

“Pressure Ulcers – Pipeline Review”
Pressure ulcers are an injury that breaks down the skin and underlying tissue. The parts of the body most at risk of developing pressure ulcers are those that are not covered by a large amount of body fat and are in direct contact with a supporting surface (bed or a wheelchair). Causes include continuous pressure, friction and shear. Treatment includes antibiotics and nutrition.

A new independent 28 page research with title ‘Pressure Ulcers – Pipeline Review, H2 2018’  guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions important players/vendors such as EyeGene Inc,Izun Pharmaceuticals Corp,MimeTech Srl,NovaLead Pharma Pvt Ltd With n-number of tables and figures examining the Pressure Ulcers the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader’s market revenue forecasts as well as analysis to 2022


Request a sample report @


HTF latest Pharmaceutical and Healthcare disease pipeline guide Pressure Ulcers – Pipeline Review, H2 2018, provides an overview of the Pressure Ulcers (Dermatology) pipeline landscape.



Report Highlights

HTF Pharmaceutical and Healthcare latest pipeline guide Pressure Ulcers – Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Pressure Ulcers (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


The Pressure Ulcers (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pressure Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, IND/CTA Filed and Preclinical stages are 1, 1 and 4 respectively.


Get customization & check discount for report @


Pressure Ulcers (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from HTF proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.



– The pipeline guide provides a snapshot of the global therapeutic landscape of Pressure Ulcers (Dermatology).

– The pipeline guide reviews pipeline therapeutics for Pressure Ulcers (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Pressure Ulcers (Dermatology) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Pressure Ulcers (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Pressure Ulcers (Dermatology)


Reasons to buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

– Find and recognize significant and varied types of therapeutics under development for Pressure Ulcers (Dermatology).

– Classify potential new clients or partners in the target demographic.

– Develop tactical initiatives by understanding the focus areas of leading companies.

– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

– Formulate corrective measures for pipeline projects by understanding Pressure Ulcers (Dermatology) pipeline depth and focus of Indication therapeutics.

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Companies Mentioned in the Report


EyeGene Inc

Izun Pharmaceuticals Corp

MimeTech Srl

NovaLead Pharma Pvt Ltd


View Detailed Table of Content @



Table of Contents

List of Tables

List of Figures


Global Markets Direct Report Coverage

Pressure Ulcers – Overview

Pressure Ulcers – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Products under Development by Companies

Pressure Ulcers – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administ




Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.



Place a Purchase Order for this Market Study (Single User License) at:

Media Contact
Company Name: HTF Market Intelligence Consulting Private Limited
Contact Person: Craig Francis
Email: Send Email
Phone: 2063171218
Address:Unit No. 429, Parsonage Road
City: Edison
State: New Jersey
Country: United States